Vaccines for COVID-19: a systematic review of feasibility and effectiveness

E Mehraeen, O Dadras, AM Afsahi… - … Current Drug Targets …, 2022 - ingentaconnect.com
Introduction: Many potential vaccines for COVID-19 are being studied and developed.
Several studies have reported on the safety and efficacy of these vaccines. This systematic …

[HTML][HTML] Development of vaccines for SARS-CoV-2

WH Ng, X Liu, S Mahalingam - F1000Research, 2020 - ncbi.nlm.nih.gov
COVID-19 emerged in late 2019 and has rapidly spread through many countries globally.
The causative SARS-CoV-2 virus was not known until recently, and there is little or no …

An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era

A Pascual-Iglesias, J Canton, AM Ortega-Prieto… - Pathogens, 2021 - mdpi.com
The emergence of SARS-CoV-2 in late 2019 led to the COVID-19 pandemic all over the
world. When the virus was first isolated and its genome was sequenced in the early months …

[PDF][PDF] A vaccine is not too far for COVID-19

SK Patel, M Pathak, R Tiwari, MI Yatoo, YS Malik… - The Journal of Infection …, 2020 - jidc.org
Over the last months and weeks of the pandemic of the Coronavirus Disease 2019 (COVID-
19)(January-May 2020) caused by the Severe acute respiratory syndrome coronavirus 2 …

Boosting immunity to COVID-19 vaccines

JA Juno, AK Wheatley - Nature medicine, 2021 - nature.com
Boosting immunity to COVID-19 vaccines | Nature Medicine Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …

Challenges and developments in universal vaccine design against SARS-CoV-2 variants

F Zhao, X Zai, Z Zhang, J Xu, W Chen - npj Vaccines, 2022 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had
become a global concern because of its unexpectedly high pathogenicity and …

COVID-19 and vaccination: myths vs science

VP Chavda, Y Chen, J Dave, ZS Chen… - Expert Review of …, 2022 - Taylor & Francis
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …